George Washington Cancer Center

Washington D.C., District of Columbia 20037

0 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, HNSCC, Marginal Zone Lymphoma, Metastatic Breast Cancer

Studies at this site

• A Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone Lymphoma — Running, not enrolling
• Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer — Running, not enrolling
• Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial) — Stopped early